233 related articles for article (PubMed ID: 32847038)
21. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
[TBL] [Abstract][Full Text] [Related]
22. CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn.
Wang J; Yin C; Pan Y; Yang Y; Li W; Ni H; Liu B; Nie H; Xu R; Wei H; Zhang Y; Li Y; Hu Q; Tai Y; Shao X; Fang J; Liu B
J Neuroinflammation; 2023 May; 20(1):109. PubMed ID: 37158939
[TBL] [Abstract][Full Text] [Related]
23. Increased CXCL13 and CXCR5 in Anterior Cingulate Cortex Contributes to Neuropathic Pain-Related Conditioned Place Aversion.
Wu XB; He LN; Jiang BC; Wang X; Lu Y; Gao YJ
Neurosci Bull; 2019 Aug; 35(4):613-623. PubMed ID: 31041693
[TBL] [Abstract][Full Text] [Related]
24. DOCK2 and phosphoinositide-3 kinase δ mediate two complementary signaling pathways for CXCR5-dependent B cell migration.
Wissmann S; Stolp B; Jímenez AM; Stein JV
Front Immunol; 2022; 13():982383. PubMed ID: 36341455
[TBL] [Abstract][Full Text] [Related]
25. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice.
Zhang Q; Cao DL; Zhang ZJ; Jiang BC; Gao YJ
J Neuroinflammation; 2016 Jul; 13(1):183. PubMed ID: 27401148
[TBL] [Abstract][Full Text] [Related]
26. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
Heinrichs M; Ashour D; Siegel J; Büchner L; Wedekind G; Heinze KG; Arampatzi P; Saliba AE; Cochain C; Hofmann U; Frantz S; Campos Ramos G
Cardiovasc Res; 2021 Nov; 117(13):2664-2676. PubMed ID: 34048536
[TBL] [Abstract][Full Text] [Related]
27. Connective tissue growth factor stimulates osteosarcoma cell migration and induces osteosarcoma metastasis by upregulating VCAM-1 expression.
Hou CH; Yang RS; Tsao YT
Biochem Pharmacol; 2018 Sep; 155():71-81. PubMed ID: 29909077
[TBL] [Abstract][Full Text] [Related]
28. IGFBP-3 stimulates human osteosarcoma cell migration by upregulating VCAM-1 expression.
Chao CC; Lee WF; Yang WH; Lin CY; Han CK; Huang YL; Fong YC; Wu MH; Lee IT; Tsai YH; Tang CH; Liu JF
Life Sci; 2021 Jan; 265():118758. PubMed ID: 33188835
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of CXCR5 and CXCL13 in mice with experimental autoimmune myocarditis.
Han FL; Liang F; Jiang TC; Liu M
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1860-1867. PubMed ID: 28485792
[TBL] [Abstract][Full Text] [Related]
30. Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition.
Cheng G; Liu C; Sun X; Zhang L; Liu L; Ouyang J; Li B
Oncol Rep; 2015 Aug; 34(2):987-94. PubMed ID: 26062797
[TBL] [Abstract][Full Text] [Related]
31. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
[TBL] [Abstract][Full Text] [Related]
32. CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.
MacDonald RJ; Yen A
In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):725-735. PubMed ID: 30276608
[TBL] [Abstract][Full Text] [Related]
33. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
[TBL] [Abstract][Full Text] [Related]
34. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
[TBL] [Abstract][Full Text] [Related]
35. Spin90 deficiency increases CXCL13-mediated B cell migration.
Park SH; Kim HR; Jun CD; Song WK; Park SG
Scand J Immunol; 2014 Sep; 80(3):191-7. PubMed ID: 24965518
[TBL] [Abstract][Full Text] [Related]
36. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer.
Wang B; Wang M; Ao D; Wei X
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188799. PubMed ID: 36103908
[TBL] [Abstract][Full Text] [Related]
37. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
Singh S; Singh R; Sharma PK; Singh UP; Rai SN; Chung LW; Cooper CR; Novakovic KR; Grizzle WE; Lillard JW
Cancer Lett; 2009 Sep; 283(1):29-35. PubMed ID: 19375853
[TBL] [Abstract][Full Text] [Related]
38. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
[TBL] [Abstract][Full Text] [Related]
39. Activated microglia promote invasion and barrier dysfunction of brain endothelial cells via regulating the CXCL13/CXCR5 axis.
Zhang Q; Jiang J; Liu Y; Ma G; Wang X; Fang B
Cell Biol Int; 2022 Sep; 46(9):1510-1518. PubMed ID: 35670241
[TBL] [Abstract][Full Text] [Related]
40. CXCL13 inhibition induce the apoptosis of MDA-MB-231 breast cancer cells through blocking CXCR5/ERK signaling pathway.
Ma JJ; Jiang L; Tong DY; Ren YN; Sheng MF; Liu HC
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8755-8762. PubMed ID: 30575916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
